background
cold
viru
infect
associ
asthma
attack
increas
bronchial
respons
even
normal
subject
possibl
mechan
includ
epitheli
damag
interact
adhes
molecul
thelper
cell
subset
object
determin
whether
cold
increas
lower
airway
inflamm
compar
atop
nonatop
normal
subject
method
thirti
healthi
volunt
atop
took
part
basehn
test
includ
viral
serolog
microbiolog
cultur
polymeras
chain
reaction
rhinoviru
infect
hrvpcr
histamin
bronchial
provoc
bronchoscopi
twenti
subject
eight
atop
underw
repeat
test
develop
cold
result
forc
expiratori
volum
one
second
fevi
significantli
lower
cold
confid
mterval
signific
increas
bronchial
respons
doubl
doserespons
slope
eight
subject
two
atop
diagnos
viral
infect
two
hrv
three
coronaviru
hcv
one
hrv
hcv
one
parainfluenza
iii
pi
one
respiratori
syncyti
viru
rsv
also
haemophilu
influenza
biopsi
cold
total
eosinophil
egl
increas
significantli
geometr
mean
p
ooa
activ
eosinophil
increas
significantli
subgroup
without
diagnos
viral
infect
particularli
atop
rhiniiic
tsuppressor
cell
also
increas
significantli
median
cell
mm
epitheli
express
intercellular
adhes
express
increas
four
atop
rhinit
cold
bronchial
wash
show
signific
increas
neutrophil
gm
conclus
lower
airway
inflamm
present
atop
nonatop
normal
subject
cold
atop
subject
differ
less
like
posit
virolog
test
like
show
activ
eosinophilia
lower
airway
despit
similar
spectrum
symptom
attack
upper
respiratori
tract
viral
infect
major
rhinovir
recent
increas
evid
associ
asthma
rhinoviru
hrv
infect
difficult
diagnos
genom
common
mani
serotyp
allow
improv
diagnosi
hrv
infect
two
studi
use
techniqu
found
particularli
high
identif
rate
hrv
asthma
exacerb
sever
studi
shown
cold
may
increas
asthma
sever
use
indirect
measur
peak
expiratori
fiow
pefr
bronchial
respons
late
asthmat
respons
allergen
howev
littl
inform
direct
effect
cold
viru
infect
immunopatholog
lower
respiratori
tract
bronchial
biopsi
influenza
mycoplasma
shown
inflammatori
featur
consist
asthma
nasal
biopsi
experiment
rhinoviru
infect
shown
evid
inflammatori
infiltr
suggest
mediat
histamin
bradykinin
may
caus
upper
airway
symptom
nasal
epitheli
cell
cultur
rhinovirus
neglig
cytopatholog
effect
compar
destruct
monolay
caus
influenza
adenoviru
nevertheless
nasal
epitheli
cell
shed
increas
vivo
experiment
rhinoviru
infect
given
high
rate
rhinoviru
infect
associ
asthma
exacerb
intrigu
note
receptor
major
rhinoviru
serotyp
intercellular
adhes
molecul
ligand
includ
integrin
present
inflammatori
cell
bind
essenti
migrat
inflammatori
cell
tissu
constitut
express
vascular
endotheli
cell
also
upregul
bronchial
epitheli
cell
asthma
suggest
mechan
inflammatori
infiltr
epithelium
viral
infect
may
upregul
direct
eflect
shown
cultur
tumour
cell
fine
indirectli
via
expans
th
thelper
cell
clone
produc
interferon
aim
studi
examin
bronchial
epitheli
tissu
natur
acquir
cold
viru
infect
order
determin
whether
differ
lower
airway
infiammatori
respons
express
atop
nonatop
subject
decid
studi
natur
acquir
cold
use
respiratori
symptom
diagnost
endpoint
experiment
infect
specif
rhinoviru
serotyp
may
necessarili
result
spectrum
symptom
inflammatori
chang
occur
common
cold
anticip
identif
viral
infect
predomin
rhinoviru
infect
previou
studi
asthmat
studi
felt
would
inappropri
bronchoscop
subject
exacerb
atop
subject
show
mild
bronchial
infiammatori
chang
may
exacerb
environment
factor
without
unaccept
risk
thirti
normal
individu
age
year
gave
written
inform
consent
take
part
studi
approv
district
research
ethic
committe
none
subject
histori
asthma
chronic
cough
wheez
dyspnoea
subject
exclud
smoke
preced
year
past
histori
packyear
smoke
fifteen
subject
select
atopi
basi
one
posit
skinprick
test
screen
five
common
inhal
allergen
normal
spirometri
forc
expiratori
volum
one
second
fevi
greater
predict
age
height
subject
recruit
novemb
march
time
cold
least
week
screen
investig
includ
brief
respiratori
symptom
questionnair
medic
examin
skinprick
test
five
common
inhal
allergen
simpl
spirometri
histamin
bronchial
provoc
test
diari
card
respiratori
symptom
peak
expiratori
flow
subject
review
day
exclud
studi
diari
card
reveal
greater
diurnal
peak
fiow
variabl
chronic
lower
respiratori
symptom
blood
taken
platelet
count
clot
screen
viral
serolog
test
nose
throat
swab
taken
hrvpcr
bronchoscopi
perform
day
later
bronchial
wash
taken
microbiolog
cultur
hrvpcr
bronchial
biopsi
immunopatholog
studi
subject
review
regularli
monthli
interv
ask
attend
review
onset
ofa
cold
lower
respiratori
symptom
cough
wheez
dyspnoea
diari
card
symptom
score
review
order
confirm
diagnosi
cold
diagnosi
base
record
cough
togeth
least
one
symptom
nasal
blockag
rhinorrhoea
wheez
dyspnoea
provid
least
one
symptom
rate
grade
moder
symptom
score
confirm
interview
doctor
clinic
examin
perform
order
exclud
seriou
respiratori
diseas
histamin
bronchial
provoc
test
polymeras
chain
reaction
pcr
nose
throat
swab
viral
serolog
repeat
follow
bronchoscopi
day
later
bronchial
wash
biopsi
taken
process
bronchial
biopsi
site
random
g
blackwel
scienc
ltd
clinic
experiment
allergi
half
subject
underw
biopsi
right
tipper
half
right
lower
lobe
basehn
altern
site
biopsi
acut
cold
diari
card
respiratori
symptom
peak
fiow
record
week
commenc
onset
cold
symptom
convalesc
viral
serolog
repeat
end
month
questionnair
diari
card
subject
complet
written
questionnair
respiratori
symptom
subject
exclud
report
wheez
breathless
absenc
ofa
cold
time
preced
month
diari
card
complet
week
baselin
record
symptom
cough
wheez
breathless
nasal
blockag
runni
nose
twice
daili
symptom
grade
nil
mild
moder
sever
peak
expiratori
flow
record
rise
retir
sleep
use
miniwright
meter
subject
instruct
record
best
three
reproduc
read
individu
diurnal
peak
flow
variat
chronic
cough
wheez
dyspnoea
exclud
diari
card
recommenc
onset
cold
record
peak
flow
symptom
continu
month
spirometri
bronchial
provoc
test
fevi
record
rest
mln
best
three
repeat
measur
use
vitalograph
dri
bellow
spiromet
vitalograph
ltd
buckingham
uk
histamin
bronchial
provoc
test
perform
accord
standard
tidal
breath
method
provid
rest
fevi
greater
predict
valu
age
height
devilbiss
nebul
driven
air
rate
output
nil
min
use
challeng
termin
fev
fallen
compar
lowest
valu
control
solut
coca
solut
maximum
concentr
mgml
histamin
doserespons
slope
sl
calcul
maximum
percentag
fall
fev
divid
cumul
dose
histamin
deliv
paramet
use
place
provoc
concentr
mani
subject
minim
respons
histamin
bronchoconstrict
maximum
dose
skinprick
test
perform
use
skintest
solut
alk
dermatophagoid
pteronyssinu
mix
grass
pollen
aspergillu
fumigatu
cat
fur
dog
hair
plu
posit
neg
control
histamin
mg
ml
sahn
subject
classifi
atop
basi
one
posit
skinprick
test
defin
skin
weal
least
mm
diamet
mm
greater
diamet
neg
control
bronchoscopi
subject
attend
bronchoscopi
fast
midnight
follow
intramuscular
premed
mg
pethidin
prochlopererazin
atropin
lignocain
solut
appli
fauc
lignocain
solut
vocal
cord
airway
olympu
bronchoscop
pass
bronchial
wash
taken
right
middl
lobe
use
two
ml
aliquot
normal
salin
cup
forcep
use
take
biopsi
right
upper
lower
lobe
scgmentalsubsegmcnt
orific
accord
random
sequenc
virolog
microbiolog
investig
nasal
swab
taken
anterior
nare
throat
swab
pass
firmli
pharynx
tonsil
swab
place
ml
transport
medium
contain
nutrient
broth
fetal
calf
serum
penicillin
streptomycin
amphotericin
b
swab
ml
aliquot
bronchial
wash
store
c
specimen
subsequ
analys
use
seminest
revers
transcriptas
rt
pcr
human
rhinovirus
hrv
incorpor
touchdown
reaction
cycl
previous
describ
ireland
et
al
primer
probe
use
follow
sequenc
rt
pcr
hrv
pcr
cultur
human
rhinovirus
sever
serotyp
use
posit
control
viru
transport
medium
use
neg
control
assay
appear
base
pair
amplif
product
taken
indic
hrv
infect
serum
sampl
loml
taken
baselin
acut
convalesc
phase
subsequ
infect
store
c
sera
test
complement
fix
antibodi
adenoviru
influenza
b
respiratori
syncyti
viru
rsv
parainfiuenza
virus
mycoplasma
pncumoniac
chlamydia
psiitaci
enzymelink
immunosorb
assay
elisa
use
detect
rise
antibodi
level
coronavirus
sera
test
dilut
ioo
consist
ratio
absorb
valu
convalesc
acut
sampl
taken
indic
recent
infect
bronchial
wash
sent
baselin
acut
phase
infect
standard
microscopi
cultur
bacteri
pathogen
virolog
cultur
signific
differ
atop
nonatop
subject
perform
cowork
previous
found
improv
diagnost
yield
cultur
procedur
ad
serolog
hrvpcr
studi
children
show
higher
rate
picornaviru
identif
asthma
exacerb
rate
confirm
hrv
infect
similar
excess
picornavirus
may
unconfirm
hrv
enterovirus
higher
preval
hrv
infect
may
explain
differ
age
group
studi
sampl
process
analys
without
knowledg
subject
viral
infect
statu
symptom
order
avoid
bia
interpret
result
one
biopsi
fix
carnoy
solut
process
shandon
citadel
automat
tissu
processor
shandon
southern
product
ltd
runcorn
uk
embed
paraffin
wax
cut
section
section
stain
monoclon
antibodi
egl
total
eosinophil
activ
eosinophil
pharmacia
milton
keyn
uk
use
streptavidin
immunoperoxidas
method
two
biopsi
embed
optimum
cut
compound
agar
stanstead
uk
snapfrozen
liquid
nitrogen
store
c
cryostat
section
cut
stain
use
monoclon
antibodi
total
helper
cd
suppressor
cell
receptor
posit
cell
dako
ltd
high
wyeomb
uk
use
avidin
biotin
complex
abc
techniqu
total
cell
count
made
biopsi
section
express
per
mm
area
tissu
area
measur
use
computer
imag
analysi
kompira
ltd
strathclyd
uk
section
also
stain
intercellular
adhes
molecul
serotec
oxford
uk
use
abc
techniqu
epitheli
express
grade
scale
colour
intens
distribut
stain
specimen
process
immedi
lavag
fluid
chill
c
aliquot
cytocentrifug
rpm
min
specimen
air
dri
stain
diffquick
reagent
differentia
count
diffferenti
cell
count
made
count
cell
consecut
high
power
field
data
test
normal
distribut
normal
probabl
plot
shapirowilk
test
logtransform
appropri
parametr
test
appli
pefr
fev
logtransform
histamin
doserespons
slope
logtransform
eosinophil
neutrophil
data
lung
function
histamin
challeng
data
cold
compar
mean
baselin
valu
use
pair
rtest
pair
test
use
compar
baselin
acut
phase
eosinophil
neutrophil
data
two
sampl
test
use
compar
chang
eosinophil
neutrophil
bronchial
respons
cold
atop
nonatop
subject
viral
diagnost
group
symptom
group
nonnorm
distribut
data
cell
icel
wilcoxon
sign
rank
test
use
compar
baselin
acut
phase
result
mannwhitney
test
compar
chang
tcell
infiltr
cold
atop
nonatop
subject
viral
diagnost
group
symptom
group
fevi
forc
expiratori
volum
one
second
sl
slope
bronchia
provoc
dose
respons
curv
cl
conftdenc
interv
mean
confid
interv
includ
zero
differ
nonsignific
level
signific
chang
within
group
p
pair
test
signific
chang
within
group
p
pair
test
thirti
subject
mean
age
year
rang
year
took
part
tabl
sixteen
male
femal
fifteen
atop
eight
rhiniti
six
grass
pollensensit
two
hous
dust
mite
sensit
mean
fev
predict
rang
predict
mean
pefr
variat
amplitud
percentag
mean
rang
three
subjeet
bronchial
hyperrespons
react
fall
ffv
concentr
histamin
lower
signific
differ
age
sex
ratio
lung
function
bronchial
respons
atop
nonatop
group
twenti
subject
return
symptom
cold
novemb
august
none
ofth
pollensensit
rhinit
present
cold
pollen
season
two
subject
default
followup
eight
subject
experi
symptom
cold
foilowup
viral
identif
made
eight
ofth
symptomat
subject
two
rhinoviru
hrv
infect
three
coronaviru
hcv
infect
two
serotyp
one
one
dual
infect
pcr
posit
hrv
serolog
posit
hcv
one
parainfluenza
iii
one
respiratori
syncyti
viru
rsv
infect
none
ofth
subject
posit
hrvpcr
baselin
high
titr
viral
serolog
bacteri
pathogen
identifi
one
case
haemophilu
influenza
isol
bronchial
wash
subject
also
rise
rsv
titr
addit
consid
efiect
atopi
also
consid
effect
posit
virolog
diagnosi
symptom
lung
function
bronchial
respons
immunohistolog
aim
analysi
determin
whether
gross
differ
subject
without
posit
virolog
test
could
account
infect
albeit
heterogen
group
pathogen
although
tnay
differ
differ
viral
infect
number
subject
specif
infect
hrv
consid
separ
subgroup
studi
subject
complain
cough
rhinorrhoea
nine
subject
complain
wheez
five
posit
virolog
test
nine
subject
complain
breathless
five
posit
virolog
test
signific
differ
symptom
sever
without
posit
virologica
test
eight
atop
nonatop
subject
experienc
cold
symptom
two
eight
atop
subject
posit
virolog
test
compar
six
ofth
nonatop
subject
two
atop
subject
complain
wheez
compar
seven
nonatop
subject
one
atop
subject
complain
breathless
compar
eight
nonatop
subject
symptom
sever
significantli
greater
breathless
nonatop
group
median
score
compar
mannwhitney
test
fev
significantli
lower
cold
mean
reduct
ci
p
tabl
pefr
peak
flow
variat
show
signific
chang
small
signific
increas
bronchial
respons
shown
mean
increas
doubl
slope
ds
dose
respons
curv
ci
ds
tabl
show
mean
chang
fev
sl
atop
nonatop
subject
egl
activ
eosinophil
respect
helper
suppressor
cell
respect
receptor
posit
cell
signific
difier
number
inflammatori
cell
present
atop
nonatop
subject
bronchial
rnucosa
baselin
number
tsuppressor
eell
greater
atop
subject
borderlin
signific
p
mannwhitneyf
test
without
posit
viral
diagnos
greater
increas
bronchial
respons
nonatop
subject
without
diagnos
viral
infect
differ
group
signific
comparison
infiammatori
cell
infiltr
bronchial
mucosa
aiopic
nonatop
subject
baselin
tabl
signific
differ
atop
nonatop
subject
ceil
count
compar
baselin
howev
greater
number
cell
atop
group
approach
level
significatic
mannwhitney
ftest
p
posit
cell
wide
scatter
inflammatori
cell
number
subject
may
account
technic
factor
sampl
process
also
pathophysiolog
factor
scatter
result
mark
studi
literatur
eosinophil
stain
shown
fig
sixteen
subject
satisfactori
bronchial
biopsi
sampl
stain
bronchoscopi
seven
show
increas
activ
eosinophil
infiltr
cold
signific
increas
infiltr
cold
tceil
immunostain
shown
fig
fourteen
subject
satisfactori
bronchial
biopsi
sampl
tccll
stain
one
ot
satisfactori
section
total
tcell
stain
tcell
number
normal
distribut
nonparametr
statist
use
analys
data
signific
increas
tsuppressor
cell
median
cell
mm
ceil
mm
wilcoxon
sign
rank
test
p
also
increas
posit
cell
although
number
small
increas
median
cell
mm
cell
mm
p
figur
show
differenti
cell
count
bronchial
wash
seventeen
subject
satisfactori
bronchial
cytolog
specimen
differenti
cell
count
signific
chang
macrophag
lymphocyt
eosinophil
epitheli
cell
howev
signific
increas
percentag
neutrophil
geometr
mean
pair
test
geometr
mean
increas
confid
interv
p
effect
atopi
viral
diagnosi
chang
infiammatori
cell
infiltr
bronchial
mucosa
shown
tabl
tabl
show
chang
baselin
number
inflammatori
cell
atop
nonatop
subject
without
posit
viral
diagnos
differ
chang
egl
infiltr
atop
nonatop
subject
without
diagnos
viral
infect
howev
difler
chang
infiltr
subgroup
graphic
repres
fig
two
eight
subject
diagnos
viral
infect
show
increas
infiltr
compar
five
eight
subject
without
diagnos
infect
without
diagnos
viral
infect
show
signific
increas
infihr
pair
test
p
subject
diagnos
infect
demonstr
larg
increas
infiltr
subject
dual
infect
rsv
haemophilu
influenza
subject
also
atop
grass
pollen
allerg
rhinit
signific
increas
cell
without
diagnos
infect
compar
diagnos
infect
two
sampl
test
p
atop
subject
like
show
increas
infiltr
nonatop
subject
differ
chang
baselin
atop
nonatop
subject
signific
two
sampl
test
p
reduct
number
major
nonatop
subject
three
four
atop
subject
show
increas
eosinophil
rhinit
signific
differ
atop
nonatop
group
without
diagnos
viral
infect
cell
greater
increas
neutrophil
bronchial
wash
diagnos
viral
infect
increas
significantli
difter
chang
without
diagnos
infect
tabl
illustr
associ
lower
respiratori
tract
symptom
bronchial
infiammatori
cell
infiltr
tabl
show
fig
neutrophil
count
bronchial
lavag
specimen
data
lognorm
distribut
statist
analysi
pig
major
sampl
show
increas
neutrophilia
acut
coryz
symptom
although
mean
increas
small
statist
signific
tabl
fold
chang
confid
interv
cl
incltid
ihe
valu
chang
indic
signific
increas
decreas
number
cell
signific
chang
baselin
within
tirotip
p
pair
test
wilcoxon
sign
rank
test
cell
borderlin
signific
chang
baselin
within
group
p
wilcoxon
sign
rank
test
signific
dilter
atop
nonatop
viral
diagnosi
group
p
comparison
chang
two
sampl
test
group
subject
report
symptom
wheez
dyspnoea
cold
subject
wheez
cold
show
increas
egl
cell
brotichi
mucosa
significantli
differ
comparison
chang
iti
wheez
signific
differ
symptom
subgroup
posit
cell
bronchial
tnucosa
neutrophil
bronchial
washitig
subject
dyspnoea
cold
show
signific
increas
cd
cell
comparison
nondyspno
subgroup
median
increas
cell
mm
compar
cellsmm
mannwhitney
tztest
subject
also
show
increas
cell
differ
significantli
frotn
nondyspno
subgroup
signific
associ
dyspnoea
chang
infiamtnatori
cell
although
increas
neutrophil
bronchial
wash
nondyspno
subgroup
thirteen
subject
satisfactori
bronchial
biopsi
sampl
stain
icaml
stain
epithehum
found
four
seven
atop
subject
none
six
nonatop
subject
icaml
express
upregul
cold
four
atop
subject
grade
scale
two
subject
increas
express
one
one
one
four
subject
identifi
viral
infect
subject
rsv
infect
togeth
haemophilu
influeriza
grade
atopi
subject
biopsi
tissu
avail
rhiniti
section
avail
five
eight
subject
viral
infect
one
hrv
two
hcv
one
hrvhcv
one
injlucuzac
studi
design
order
determin
effect
common
cold
lower
airway
inflarnm
compar
respons
atopi
nonatop
subject
studi
shown
presenc
bronchial
inflamm
healthi
adult
subject
complain
symptom
comtnon
cold
demonstr
two
distinct
group
among
subject
virolog
proven
infect
without
rel
rise
neutrophil
characterist
former
group
wherea
activ
eosinophil
infiltr
present
latter
despit
differ
symptom
score
similar
two
group
atopi
rhiniti
factor
associ
develop
activ
eosinophil
inflamm
bronchial
mucosa
major
subject
show
reduc
fevi
increas
airway
respons
neutrophil
total
egl
eosinophil
suppressor
tlymphocyt
regardless
atopi
ptesenc
viral
infect
percept
symptom
common
cold
subject
observ
eould
influenc
result
lung
function
bronchial
provoc
test
stain
count
biopsi
iavag
specimen
perform
without
knowledg
subject
eoryz
symptom
infect
statu
ilnd
indic
mani
subject
symptotn
tradit
thought
indic
upper
respiratori
tract
infect
evid
lower
respiratori
tract
inflamm
seem
like
total
eosinophil
neutrophil
increas
part
acut
granulocyt
infiltr
wherea
tsuppressor
cell
may
involv
killer
cell
respons
viral
infect
role
subject
unabl
identifi
pathogen
less
clear
number
subject
hrv
infect
consid
separ
howev
methodolog
hrv
rtpcr
previous
well
valid
result
adult
asthtna
exacerb
compar
well
studi
children
use
similar
techniqu
latter
studi
higher
rate
picornavirus
identifi
pcr
confirm
rate
hrv
similar
excess
picornavirus
may
account
hrv
enteroviru
infect
former
like
differ
two
studi
may
reflect
age
group
involv
bronchial
immunopatholog
hrv
case
distinct
despit
receptor
major
hrv
serotyp
express
bronchial
epithelium
limit
four
atop
rhinil
subject
previous
abl
show
bronchial
epitheli
express
nonasthmat
wherea
constitut
express
vascular
endothelium
howev
previou
studi
compar
asthmat
nonatop
nonrhinit
thu
find
studi
suggest
may
upregul
lower
airway
epithelium
allerg
rhiniti
well
asthma
icami
express
diagnos
viral
infect
one
atop
rhinit
subject
combin
rsv
togeth
haemophilu
influenza
infect
heterosexu
never
smoke
except
symptom
made
full
rapid
recoveri
bronchial
lavag
demonstr
high
neutrophilia
although
small
studi
believ
find
suggest
tendenc
often
suspect
clinic
practic
allerg
subject
report
allerg
inflamm
cold
could
explain
low
diagnost
rate
viral
infect
particular
atop
group
despit
combin
pcr
serolog
diagnost
techniqu
given
high
yield
viral
diagnos
previou
studi
interest
signific
difler
symptom
among
atop
nonatop
subject
save
breathless
paradox
common
among
nonatop
subject
lower
respiratori
tract
symptom
quit
common
among
subject
uncompl
cold
provid
clinic
correl
inflammatori
infiltr
especi
cell
investig
found
slight
differ
symptomatolog
atop
subject
experiment
hrv
infect
symptom
tend
earlier
onset
sever
evid
preced
hrv
infect
studi
shown
marker
allerg
inflamm
detect
distant
site
atop
subject
djukanov
et
al
show
greater
number
inflammatori
cell
bronchial
mucosa
atop
rhinit
nonatop
normal
contrast
found
differ
atop
nonatop
subject
baselin
half
atop
subject
rhiniti
studi
laboratori
shown
constitut
upregul
cytokin
granulocyt
macrophagecoloni
stimul
factor
gmcsf
nasal
mucosa
atop
nonrhinit
eczema
thu
perhap
surpris
activ
eosinophil
increas
bronchial
mucosa
atop
rhinit
episod
respiratori
symptom
previou
studi
immunopatholog
common
cold
concentr
experiment
hrv
infect
examin
mainli
nasal
secret
peripher
blood
studi
bronchial
patholog
halperin
et
al
isol
hrv
lower
airway
experiment
infect
use
bronchoscop
techniqu
minimis
contamin
upper
respiratori
tract
calhoun
et
al
found
subject
experiment
infect
show
increas
eosinophil
bronchoa
veolar
lavag
specimen
follow
allergen
challeng
amplifi
respons
atop
rhinit
subject
consist
increas
allergen
respons
among
similar
subject
previou
studi
studi
cold
produc
conflict
data
neutrophilia
consist
found
nasal
secret
togeth
shed
epitheli
cell
levandowski
show
reduct
lesser
extent
cell
peripher
blood
infect
suggest
might
indic
recruit
cell
site
inflamm
howev
investig
found
neutrophil
monocyt
nasal
secret
other
abl
find
increas
inflammatori
cell
nasal
biopsi
suggest
tbat
symptom
common
cold
infect
might
caus
mediat
histamin
kinin
hsia
et
al
show
increas
product
interferon
j
peripher
blood
mononuclear
cell
invers
relat
sever
cold
also
show
increas
natur
killer
nk
cellmedi
cytotox
antigenstimul
blastogenesi
skoner
et
al
show
increas
peripher
blood
total
leucocyt
lymphocyt
especi
cd
dr
decreas
nk
cell
activ
lymphoprolif
respons
particularli
nonatop
subject
subtl
differ
peripher
blood
respons
atop
nonatop
subject
tendenc
later
respons
atop
allerg
group
peripher
blood
chang
indic
system
immun
respons
hrv
find
indic
healthi
nonasthmat
subject
symptom
common
cold
develop
bronchial
inflamm
includ
infiltr
eosinophil
neutrophil
tsuppressor
cell
atop
rhinit
subject
like
show
allerg
inflamm
activ
eosinophilia
least
like
diagnos
viral
g
blackwel
scienc
ltd
clinic
experimenl
allergi
infect
therefor
symptom
typic
common
cold
may
caus
airway
inflamm
absenc
viral
infect
exposur
aeroallergen
possibl
environment
pollut
consid
altern
trigger
cold
symptom
